Who wins, who loses with biogenerics By: MarketWatch August 28, 2009 at 17:00 PM EDT Who wins, who loses if and when generic biotech drugs, also known as biogenerics, are finally allowed on the U.S. market? Read More >> Related Stocks: Amgen Biogen Idec Novartis Ag ADR Pfizer Roche Holding AG Basel American Depositary Shares